Novel small molecule inhibitors of the OLIG2 transcription factor: promising new therapeutics for glioblastoma

Future Oncol. 2016;12(8):1001-4. doi: 10.2217/fon-2015-0078. Epub 2016 Feb 12.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Basic Helix-Loop-Helix Transcription Factors / antagonists & inhibitors*
  • Basic Helix-Loop-Helix Transcription Factors / chemistry
  • Basic Helix-Loop-Helix Transcription Factors / metabolism*
  • Drug Discovery
  • Glioblastoma / drug therapy
  • Glioblastoma / metabolism*
  • Humans
  • Molecular Targeted Therapy
  • Nerve Tissue Proteins / antagonists & inhibitors*
  • Nerve Tissue Proteins / chemistry
  • Nerve Tissue Proteins / metabolism*
  • Oligodendrocyte Transcription Factor 2

Substances

  • Antineoplastic Agents
  • Basic Helix-Loop-Helix Transcription Factors
  • Nerve Tissue Proteins
  • OLIG2 protein, human
  • Oligodendrocyte Transcription Factor 2